| Texas Fertility Center | 62.7 | 3 | 1 |
| Prelude Fertility | 62.7 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 62.7 | 3 | 1 |
| Facial plastic surgery & aesthetic medicine | 60.0 | 6 | 0 |
| Colorado Center for Reproductive Medicine | 53.9 | 2 | 1 |
| Sher Fertility | 53.9 | 2 | 1 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 53.9 | 2 | 1 |
| Mayo Clinic | 49.6 | 4 | 0 |
| Cleveland Clinic | 49.6 | 4 | 0 |
| Trends in Amplification | 49.6 | 4 | 0 |
| National Institute for Occupational Safety and Health | 42.7 | 3 | 0 |
| Q229883 | 42.7 | 3 | 0 |
| United States National Institutes of Health | 42.7 | 3 | 0 |
| JAMA Facial Plastic Surgery | 42.7 | 3 | 0 |
| Psychological Reports | 42.7 | 3 | 0 |
| Applied Biosafety | 42.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 42.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 42.7 | 3 | 0 |
| Industrial biotechnology (New Rochelle, N.Y.) | 42.7 | 3 | 0 |
| Pacific Fertility Center | 42.7 | 3 | 0 |
| Office of Readiness and Response | 42.7 | 3 | 0 |
| Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis | 42.7 | 3 | 0 |
| Clinical trial NCT07597382 | 42.7 | 3 | 0 |
| Clinical trial NCT07585825 | 42.7 | 3 | 0 |
| Clinical trial NCT07571616 | 42.7 | 3 | 0 |
| Clinical trial NCT07571629 | 42.7 | 3 | 0 |
| Clinical trial NCT07611032 | 42.7 | 3 | 0 |
| American Society for Reproductive Medicine | 41.4 | 1 | 1 |
| Reproductive Medicine Associates of New York | 41.4 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 41.4 | 1 | 1 |
| assisted reproductive technology | 40.0 | 0 | 3 |
| fertility clinic | 40.0 | 0 | 3 |
| Fertility and Sterility | 40.0 | 0 | 3 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 40.0 | 0 | 3 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | 40.0 | 0 | 3 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 40.0 | 0 | 3 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 40.0 | 0 | 3 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 40.0 | 0 | 3 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 40.0 | 0 | 3 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 40.0 | 0 | 3 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 40.0 | 0 | 3 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 40.0 | 0 | 3 |
| Androgenicity and fertility treatment in women with unexplained infertility | 40.0 | 0 | 3 |
| Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates | 40.0 | 0 | 3 |
| Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility | 40.0 | 0 | 3 |
| Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes | 40.0 | 0 | 3 |
| Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database | 40.0 | 0 | 3 |
| GYN-FIV a.s. | 40.0 | 0 | 3 |
| Nucleic Acids Research | 33.9 | 2 | 0 |
| Newsweek | 33.9 | 2 | 0 |
| Administration Science Quarterly | 33.9 | 2 | 0 |
| Ferring Pharmaceuticals | 33.9 | 2 | 0 |
| March of Dimes | 33.9 | 2 | 0 |
| Bulletin of the Atomic Scientists | 33.9 | 2 | 0 |
| Epi Info | 33.9 | 2 | 0 |
| American Journal of Medical Quality | 33.9 | 2 | 0 |
| American Journal of Men's Health | 33.9 | 2 | 0 |
| American Journal of Orthodontics and Dentofacial Orthopedics | 33.9 | 2 | 0 |
| American Journal of Translational Research | 33.9 | 2 | 0 |
| Biomedical Optics Express | 33.9 | 2 | 0 |
| ClinicalTrials.gov | 33.9 | 2 | 0 |
| dbSNP | 33.9 | 2 | 0 |
| Ergonomics in Design | 33.9 | 2 | 0 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | 33.9 | 2 | 0 |
| Geriatric orthopaedic surgery & rehabilitation | 33.9 | 2 | 0 |
| HSS Journal | 33.9 | 2 | 0 |
| Indian Journal of Psychological Medicine | 33.9 | 2 | 0 |
| Journal of Biomolecular Screening | 33.9 | 2 | 0 |
| Journal of Fire Sciences | 33.9 | 2 | 0 |
| Journal of Positive Behavior Interventions | 33.9 | 2 | 0 |
| Journal of Psychoeducational Assessment | 33.9 | 2 | 0 |
| Journal of Research in Music Education | 33.9 | 2 | 0 |
| LabCorp | 33.9 | 2 | 0 |
| Preventing Chronic Disease | 33.9 | 2 | 0 |
| Proceedings of the Human Factors and Ergonomics Society Annual Meeting | 33.9 | 2 | 0 |
| Western Journal of Medicine | 33.9 | 2 | 0 |
| Simulation & Gaming | 33.9 | 2 | 0 |
| Topics in Early Childhood Special Education | 33.9 | 2 | 0 |
| UPDATE: Applications of Research in Music Education | 33.9 | 2 | 0 |
| Ulster Medical Journal | 33.9 | 2 | 0 |
| Violence Against Women | 33.9 | 2 | 0 |
| The AAPS Journal | 33.9 | 2 | 0 |
| Rice | 33.9 | 2 | 0 |
| Journal of Correctional Health Care | 33.9 | 2 | 0 |
| Gastrointestinal Endoscopy | 33.9 | 2 | 0 |
| New Labor Forum | 33.9 | 2 | 0 |
| Antitrust Bulletin | 33.9 | 2 | 0 |
| AAPS PharmSciTech | 33.9 | 2 | 0 |
| International Journal of Mental Health Systems | 33.9 | 2 | 0 |
| Technology in Cancer Research and Treatment | 33.9 | 2 | 0 |
| Learning Disability Quarterly | 33.9 | 2 | 0 |
| American String Teacher | 33.9 | 2 | 0 |
| Journal of Urban Health | 33.9 | 2 | 0 |
| Cell Transplantation | 33.9 | 2 | 0 |
| Neural Development | 33.9 | 2 | 0 |
| Journal of International Marketing | 33.9 | 2 | 0 |
| North American Archaeologist | 33.9 | 2 | 0 |
| International Journal of Qualitative Methods | 33.9 | 2 | 0 |
| The Review of Black Political Economy | 33.9 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 33.9 | 2 | 0 |
| International Journal of Educational Reform | 33.9 | 2 | 0 |
| Environmental Health Insights | 33.9 | 2 | 0 |
| Natural Product Communications | 33.9 | 2 | 0 |
| HealthGrades | 33.9 | 2 | 0 |
| National Survey of Family Growth | 33.9 | 2 | 0 |
| National Vital Statistics System | 33.9 | 2 | 0 |
| NIOSH Power Tools Database | 33.9 | 2 | 0 |
| Q20641742 | 33.9 | 2 | 0 |
| Oregon Graduate Center | 33.9 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 33.9 | 2 | 0 |
| Childhood Obesity | 33.9 | 2 | 0 |
| Hispanic health care international : the official journal of the National Association of Hispanic Nurses | 33.9 | 2 | 0 |
| The Journal of clinical and aesthetic dermatology | 33.9 | 2 | 0 |
| Annals of Neurosciences | 33.9 | 2 | 0 |
| Alcohol research : current reviews | 33.9 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 33.9 | 2 | 0 |
| Pulmonary circulation | 33.9 | 2 | 0 |
| Dermato-endocrinology | 33.9 | 2 | 0 |
| British Heart Journal | 33.9 | 2 | 0 |
| United European gastroenterology journal | 33.9 | 2 | 0 |
| The western journal of emergency medicine | 33.9 | 2 | 0 |
| Craniomaxillofacial trauma & reconstruction | 33.9 | 2 | 0 |
| Psychiatry | 33.9 | 2 | 0 |
| Advances in Wound Care | 33.9 | 2 | 0 |
| Mycobiology | 33.9 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 33.9 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 33.9 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 33.9 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 33.9 | 2 | 0 |
| Simulation & games | 33.9 | 2 | 0 |
| NCHS data brief | 33.9 | 2 | 0 |
| Magnetic resonance insights | 33.9 | 2 | 0 |
| Biomedical informatics insights | 33.9 | 2 | 0 |
| Clinical Medicine Insights. Cardiology | 33.9 | 2 | 0 |
| Clinical medicine insights. Case reports | 33.9 | 2 | 0 |
| Clinical medicine insights. Pathology | 33.9 | 2 | 0 |
| Nutrition and metabolic insights | 33.9 | 2 | 0 |
| Allergy & rhinology (Providence, R.I.) | 33.9 | 2 | 0 |
| i-Perception | 33.9 | 2 | 0 |
| Journal of Central Nervous System Disease | 33.9 | 2 | 0 |
| Plastic surgery (Oakville, Ont.) | 33.9 | 2 | 0 |
| MMWR supplements | 33.9 | 2 | 0 |
| Transgender Health | 33.9 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 33.9 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 33.9 | 2 | 0 |
| San Diego Fertility Center | 33.9 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 33.9 | 2 | 0 |
| Fertility Center of Las Vegas | 33.9 | 2 | 0 |
| Shady Grove Fertility Center | 33.9 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 33.9 | 2 | 0 |
| Johns Hopkins Medicine | 33.9 | 2 | 0 |
| Journal of Patient Experience | 33.9 | 2 | 0 |
| OTO Open | 33.9 | 2 | 0 |
| Advances in Methods and Practices in Psychological Science | 33.9 | 2 | 0 |
| Abstracts in Anthropology | 33.9 | 2 | 0 |
| Journal of Chinese Writing Systems | 33.9 | 2 | 0 |
| bidirectional encoder representations from transformers | 33.9 | 2 | 0 |
| Health Equity | 33.9 | 2 | 0 |
| Christopher R. Conley | 33.9 | 2 | 0 |
| Journal of patient safety and risk management | 33.9 | 2 | 0 |
| Journal of Advertising Education | 33.9 | 2 | 0 |
| International Journal of Cosmetic Surgery and Aesthetic Dermatology | 33.9 | 2 | 0 |
| Q96602914 | 33.9 | 2 | 0 |
| Cultures of Science | 33.9 | 2 | 0 |
| Handbook of Practice Management | 33.9 | 2 | 0 |
| Plastic Surgery Case Studies | 33.9 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 33.9 | 2 | 0 |
| data.cdc.gov | 33.9 | 2 | 0 |
| Equity in education & society | 33.9 | 2 | 0 |
| Healthcare Infection Control Practices Advisory Committee | 33.9 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 33.9 | 2 | 0 |
| Progyny, Inc. | 33.9 | 2 | 0 |
| Clinical Pathology | 33.9 | 2 | 0 |
| WebMD Magazine | 33.9 | 2 | 0 |
| GoodLeap | 31.7 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 31.7 | 0 | 2 |
| Reproductive Medicine and Biology | 31.7 | 0 | 2 |
| Naprotechnology | 31.7 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 31.7 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 31.7 | 0 | 2 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 31.7 | 0 | 2 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 31.7 | 0 | 2 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 31.7 | 0 | 2 |
| Q28344605 | 31.7 | 0 | 2 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 31.7 | 0 | 2 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 31.7 | 0 | 2 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 31.7 | 0 | 2 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 31.7 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 31.7 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 31.7 | 0 | 2 |
| Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 31.7 | 0 | 2 |
| Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues | 31.7 | 0 | 2 |
| Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction. | 31.7 | 0 | 2 |
| Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles | 31.7 | 0 | 2 |
| A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) | 31.7 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. | 31.7 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 31.7 | 0 | 2 |
| Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer | 31.7 | 0 | 2 |
| Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature | 31.7 | 0 | 2 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 31.7 | 0 | 2 |
| Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort | 31.7 | 0 | 2 |
| Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation | 31.7 | 0 | 2 |
| Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Ovarian stimulation in patients with breast cancer | 31.7 | 0 | 2 |
| Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience | 31.7 | 0 | 2 |
| Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report | 31.7 | 0 | 2 |
| Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze | 31.7 | 0 | 2 |
| Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study | 31.7 | 0 | 2 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 31.7 | 0 | 2 |
| Optimal timing for elective egg freezing | 31.7 | 0 | 2 |
| Predictive value of sperm motility characteristics assessed by computer-assisted sperm analysis in intrauterine insemination with superovulation in couples with unexplained infertility | 31.7 | 0 | 2 |
| Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe? | 31.7 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 31.7 | 0 | 2 |
| Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer | 31.7 | 0 | 2 |
| Effectiveness and treatment for unexplained infertility | 31.7 | 0 | 2 |
| Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles | 31.7 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 31.7 | 0 | 2 |
| Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation | 31.7 | 0 | 2 |
| Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility | 31.7 | 0 | 2 |
| Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort | 31.7 | 0 | 2 |
| The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Sperm chromatin structure assay results in Nigerian men with unexplained infertility | 31.7 | 0 | 2 |
| Outcomes of ovarian stimulation after treatment with chemotherapy | 31.7 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Mature oocyte retrieval during laparotomic debulking surgery following random-start controlled ovarian stimulation for fertility preservation in a patient with suspected ovarian cancer | 31.7 | 0 | 2 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 31.7 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 31.7 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| A reassessment of comparative pregnancy and implantation rates following embryo transfer in recipients vs their infertile donors also trying to conceive in the background of performing salpingectomy for hydrosalpinx. | 31.7 | 0 | 2 |
| Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction | 31.7 | 0 | 2 |
| Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction | 31.7 | 0 | 2 |
| Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report | 31.7 | 0 | 2 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis. | 31.7 | 0 | 2 |
| Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial | 31.7 | 0 | 2 |
| Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction | 31.7 | 0 | 2 |
| Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles | 31.7 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 31.7 | 0 | 2 |
| Optimizing natural fertility | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology | 31.7 | 0 | 2 |
| Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients | 31.7 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery | 31.7 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 31.7 | 0 | 2 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 31.7 | 0 | 2 |
| Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Elective single-embryo transfer | 31.7 | 0 | 2 |
| Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature | 31.7 | 0 | 2 |
| Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer | 31.7 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 31.7 | 0 | 2 |
| Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics | 31.7 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 31.7 | 0 | 2 |
| A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone | 31.7 | 0 | 2 |
| Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders | 31.7 | 0 | 2 |
| An Integrated Approach to Male-Factor Subfertility: Bridging the Gap Between Fertility Specialists Trained in Urology and Gynaecology | 31.7 | 0 | 2 |
| Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients | 31.7 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 31.7 | 0 | 2 |
| Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy | 31.7 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility | 31.7 | 0 | 2 |
| Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response | 31.7 | 0 | 2 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 31.7 | 0 | 2 |
| Performing the embryo transfer: a guideline | 31.7 | 0 | 2 |
| Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion | 31.7 | 0 | 2 |
| The case for aromatase inhibitors use in Oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in Breast Cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate | 31.7 | 0 | 2 |
| Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study | 31.7 | 0 | 2 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 31.7 | 0 | 2 |
| Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). | 31.7 | 0 | 2 |
| In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. | 31.7 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 31.7 | 0 | 2 |
| Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles | 31.7 | 0 | 2 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 31.7 | 0 | 2 |
| Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies | 31.7 | 0 | 2 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 31.7 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in cancer patients | 31.7 | 0 | 2 |
| Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients. | 31.7 | 0 | 2 |
| Chromatin fluorescence characteristics and standard semen analysis parameters: correlations observed in andrology testing among 136 males referred for infertility evaluation | 31.7 | 0 | 2 |
| Cycle-to-cycle variation in utero-ovarian hemodynamic indices in ovarian stimulation and natural cycles of the same women and its effect on the outcome of assisted reproduction treatment. | 31.7 | 0 | 2 |
| Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction | 31.7 | 0 | 2 |
| Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. | 31.7 | 0 | 2 |
| Ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Mole modifications following controlled ovarian stimulation for assisted reproduction technologies | 31.7 | 0 | 2 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 31.7 | 0 | 2 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 31.7 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 31.7 | 0 | 2 |
| Ovarian stimulation in assisted reproduction. | 31.7 | 0 | 2 |
| Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. | 31.7 | 0 | 2 |
| Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer | 31.7 | 0 | 2 |
| Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Preprogrammed, unmonitored ovarian stimulation reduces expense without compromising the outcome of assisted reproduction | 31.7 | 0 | 2 |
| Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression | 31.7 | 0 | 2 |
| Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles | 31.7 | 0 | 2 |
| Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count | 31.7 | 0 | 2 |
| Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. | 31.7 | 0 | 2 |
| Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients | 31.7 | 0 | 2 |
| First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation | 31.7 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 31.7 | 0 | 2 |
| An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial | 31.7 | 0 | 2 |
| Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 31.7 | 0 | 2 |
| Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation | 31.7 | 0 | 2 |
| Role of semen analysis in subfertile couples | 31.7 | 0 | 2 |
| The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 31.7 | 0 | 2 |
| Semen analysis in adolescent cancer patients prior to bone marrow transplantation: when is it too late for fertility preservation? | 31.7 | 0 | 2 |
| Follicular fluid-induced acrosome reaction distinguishes a subgroup of men with unexplained infertility not identified by semen analysis | 31.7 | 0 | 2 |
| Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen | 31.7 | 0 | 2 |
| Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility | 31.7 | 0 | 2 |
| LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. | 31.7 | 0 | 2 |
| Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer | 31.7 | 0 | 2 |
| IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis | 31.7 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. | 31.7 | 0 | 2 |
| Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study | 31.7 | 0 | 2 |
| Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) | 31.7 | 0 | 2 |
| Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation | 31.7 | 0 | 2 |
| Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility | 31.7 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 31.7 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. | 31.7 | 0 | 2 |
| Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial | 31.7 | 0 | 2 |
| Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome. | 31.7 | 0 | 2 |
| Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment | 31.7 | 0 | 2 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 31.7 | 0 | 2 |
| Comparison of the semen analysis results obtained from two branded computer-aided sperm analysis systems | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation | 31.7 | 0 | 2 |
| A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility | 31.7 | 0 | 2 |
| Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'. | 31.7 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 31.7 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 31.7 | 0 | 2 |
| Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya | 31.7 | 0 | 2 |
| Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer | 31.7 | 0 | 2 |
| Ovarian stimulation for fertility preservation in patients with cancer | 31.7 | 0 | 2 |
| Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation | 31.7 | 0 | 2 |
| The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium. | 31.7 | 0 | 2 |
| Effective method for emergency fertility preservation: random-start controlled ovarian stimulation | 31.7 | 0 | 2 |
| Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial | 31.7 | 0 | 2 |
| Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 31.7 | 0 | 2 |
| Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study | 31.7 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 31.7 | 0 | 2 |
| Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Fertility preservation with ovarian stimulation protocols prior to cancer treatment | 31.7 | 0 | 2 |
| An analysis of the impact of embryo transfer difficulty on live birth rates, using a standardised grading system | 31.7 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 31.7 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 31.7 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 31.7 | 0 | 2 |
| Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial | 31.7 | 0 | 2 |
| Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women | 31.7 | 0 | 2 |
| Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy | 31.7 | 0 | 2 |
| Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients | 31.7 | 0 | 2 |
| Cumulative pregnancy and live birth rates through assisted reproduction in women 44-45 years of age: is there any hope? | 31.7 | 0 | 2 |
| Does ovarian stimulation regimen affect IVF outcome? a two-centre, real-world retrospective study using predominantly cleavage-stage, single embryo transfer | 31.7 | 0 | 2 |
| The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer | 31.7 | 0 | 2 |
| Evaluation of trend in semen analysis for 11 years in subjects attending a fertility clinic in India. | 31.7 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 31.7 | 0 | 2 |
| The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience. | 31.7 | 0 | 2 |
| Successful controlled ovarian stimulation despite elevated hCG levels after first-trimester abortion in the context of fertility preservation | 31.7 | 0 | 2 |
| Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients | 31.7 | 0 | 2 |
| Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation. | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes | 31.7 | 0 | 2 |
| The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment | 31.7 | 0 | 2 |
| Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates | 31.7 | 0 | 2 |
| Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer | 31.7 | 0 | 2 |
| A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy | 31.7 | 0 | 2 |
| Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? | 31.7 | 0 | 2 |
| Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation | 31.7 | 0 | 2 |
| The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. | 31.7 | 0 | 2 |
| Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT | 31.7 | 0 | 2 |
| Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. | 31.7 | 0 | 2 |
| The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology | 31.7 | 0 | 2 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 31.7 | 0 | 2 |
| Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone | 31.7 | 0 | 2 |
| Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation | 31.7 | 0 | 2 |
| Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure | 31.7 | 0 | 2 |
| The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. | 31.7 | 0 | 2 |
| Double embryo transfer gives good pregnancy and live birth rates in poor responders with a modest increase in multiple birth rates: results from an observational study | 31.7 | 0 | 2 |
| Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. | 31.7 | 0 | 2 |
| Intermittent vaginal injections of gonadotrophins for ovarian stimulation in IVF treatment | 31.7 | 0 | 2 |
| Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. | 31.7 | 0 | 2 |
| New alternative to infertility treatment for women without ovarian stimulation. | 31.7 | 0 | 2 |
| Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation | 31.7 | 0 | 2 |
| Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births | 31.7 | 0 | 2 |
| Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study | 31.7 | 0 | 2 |
| Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group | 31.7 | 0 | 2 |
| Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study | 31.7 | 0 | 2 |
| Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles | 31.7 | 0 | 2 |
| Endocrinology: Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation | 31.7 | 0 | 2 |
| Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older | 31.7 | 0 | 2 |
| Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme | 31.7 | 0 | 2 |
| Growth hormone, oestradiol, progesterone and testosterone concentrations in follicular fluid after ovarian stimulation with various regimes for assisted reproduction | 31.7 | 0 | 2 |
| Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer | 31.7 | 0 | 2 |
| Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon-α. | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 31.7 | 0 | 2 |
| On the Origins of the Semen Analysis: A Close Relationship with the History of the Reproductive Medicine | 31.7 | 0 | 2 |
| Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment | 31.7 | 0 | 2 |
| Do trained reproductive endocrinologists perform better than their trainees? Comparing clinical pregnancy rates and live birth rates after transfer of single fresh blastocysts. | 31.7 | 0 | 2 |
| Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients | 31.7 | 0 | 2 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 31.7 | 0 | 2 |
| Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report | 31.7 | 0 | 2 |
| Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study | 31.7 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| Semen quality of consecutive ejaculates from cancer patients for fertility preservation | 31.7 | 0 | 2 |
| Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome | 31.7 | 0 | 2 |
| Use of fetal oocytes in assisted reproduction | 31.7 | 0 | 2 |
| Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Cetrotide confirmatory trial of cetrorelix/0.25 mg in 26 women undergoing ovarian stimulation with recombinant follicle stimulating hormones for IVF, ICSI and embryo transfer (ET). | 31.7 | 0 | 2 |
| Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization--embryo transfer treatment: a comparison between conception and non-conception cycles | 31.7 | 0 | 2 |
| Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme | 31.7 | 0 | 2 |
| Treatment of patients with unexplained infertility: gamete intrafallopian transfer (GIFT) versus tubal embryo transfer (TET) | 31.7 | 0 | 2 |
| Practice patterns among reproductive endocrinologists: further aspects of the infertility evaluation. | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Practice patterns among reproductive endocrinologists: the infertility evaluation | 31.7 | 0 | 2 |
| Expectations for success in fertility treatment involving assisted reproduction | 31.7 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure | 31.7 | 0 | 2 |
| Predictors of psychological distress in patients starting IVF treatment: infertility-specific versus general psychological characteristics | 31.7 | 0 | 2 |
| Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction? | 31.7 | 0 | 2 |
| Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana | 31.7 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 31.7 | 0 | 2 |
| Subnormal sperm parameters in conventional semen analysis are associated with discrepancies between fertilization and pregnancy rates in in-vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation | 31.7 | 0 | 2 |
| Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer | 31.7 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 31.7 | 0 | 2 |
| AIUM practice guideline for ultrasonography in reproductive medicine | 31.7 | 0 | 2 |
| 'Elective single embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances': AGAINST: SET maintains live birth rates and provides unique advantages | 31.7 | 0 | 2 |
| Suitable fresh embryo transfer strategy for mild ovarian stimulation with clomiphene citrate | 31.7 | 0 | 2 |
| Endometrial Scratch Injury Induces Higher Pregnancy Rate for Women With Unexplained Infertility Undergoing IUI With Ovarian Stimulation: A Randomized Controlled Trial | 31.7 | 0 | 2 |
| Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'. | 31.7 | 0 | 2 |
| Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women | 31.7 | 0 | 2 |
| Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation | 31.7 | 0 | 2 |
| In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel | 31.7 | 0 | 2 |
| The expected cumulative incidence of live birth of patients starting IVF treatment at age 41 years or older | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer | 31.7 | 0 | 2 |
| Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors? | 31.7 | 0 | 2 |
| Misconduct in third-party assisted reproduction: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation | 31.7 | 0 | 2 |
| Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer | 31.7 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee | 31.7 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine | 31.7 | 0 | 2 |
| Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction? | 31.7 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 31.7 | 0 | 2 |
| Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates | 31.7 | 0 | 2 |
| Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction | 31.7 | 0 | 2 |
| Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer | 31.7 | 0 | 2 |
| Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents | 31.7 | 0 | 2 |
| Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved | 31.7 | 0 | 2 |
| Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer | 31.7 | 0 | 2 |
| Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle | 31.7 | 0 | 2 |
| Single Human Embryo Transfer in Assisted Reproduction Programs | 31.7 | 0 | 2 |
| Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients | 31.7 | 0 | 2 |
| Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol | 31.7 | 0 | 2 |
| GnRH Agonist at Embryo Transfer: IVF Outcomes | 31.7 | 0 | 2 |
| Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction | 31.7 | 0 | 2 |
| Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression | 31.7 | 0 | 2 |
| Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) | 31.7 | 0 | 2 |
| Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle? | 31.7 | 0 | 2 |
| Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles | 31.7 | 0 | 2 |
| Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol | 31.7 | 0 | 2 |
| Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Neonatal outcomes following different ovarian stimulation protocols in fresh single embryo transfer | 31.7 | 0 | 2 |
| What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program | 31.7 | 0 | 2 |
| Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment | 31.7 | 0 | 2 |
| Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment | 31.7 | 0 | 2 |
| Random-start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer | 31.7 | 0 | 2 |
| Biomarkers of Ovarian Reserve and Correlation With IVF Treatments | 31.7 | 0 | 2 |
| Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF) | 31.7 | 0 | 2 |
| Egg Freezing Pilot Study | 31.7 | 0 | 2 |
| MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer | 31.7 | 0 | 2 |
| Temporally Splitting Ovarian Stimulation and Embryo Transfer | 31.7 | 0 | 2 |
| Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| The Accuracy of Endometrial Ultrasound to Predict Implantation | 31.7 | 0 | 2 |
| Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer | 31.7 | 0 | 2 |
| Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility | 31.7 | 0 | 2 |
| Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates | 31.7 | 0 | 2 |
| Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial. | 31.7 | 0 | 2 |
| Endometrial Scratch Injury in Women With Unexplained Infertility Undergoing IUI | 31.7 | 0 | 2 |
| HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients | 31.7 | 0 | 2 |
| Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment | 31.7 | 0 | 2 |
| Fertility Preservation in Breast Cancer Patients | 31.7 | 0 | 2 |
| To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment | 31.7 | 0 | 2 |
| NATural Ovarian Stimulation | 31.7 | 0 | 2 |
| Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles | 31.7 | 0 | 2 |
| Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients | 31.7 | 0 | 2 |
| HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients | 31.7 | 0 | 2 |
| A randomized trial between GIFT and ovarian stimulation for the treatment of unexplained infertility and failed artificial insemination by donor | 31.7 | 0 | 2 |
| The performance of primary and secondary unexplained infertility in an in vitro fertilization-embryo transfer program | 31.7 | 0 | 2 |
| Outcome of in-vitro fertilization and embryo transfer after different regimens of ovarian stimulation | 31.7 | 0 | 2 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 31.7 | 0 | 2 |
| Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 31.7 | 0 | 2 |
| An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme | 31.7 | 0 | 2 |
| The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Morphometric characteristics of endometrial biopsies after different types of ovarian stimulation for infertility treatment | 31.7 | 0 | 2 |
| Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility? | 31.7 | 0 | 2 |
| Sonographically monitored ovarian stimulation for assisted reproduction: a prospective, blind study | 31.7 | 0 | 2 |
| In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis | 31.7 | 0 | 2 |
| Fallopian Tube Sperm Perf usion Has No Advantage over Intra-uterine Insemination when Used in Combination with Ovarian Stimulation for the Treatment of Unexplained Infertility | 31.7 | 0 | 2 |
| Methodology of human embryo transfer following assisted reproduction | 31.7 | 0 | 2 |
| Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts | 31.7 | 0 | 2 |
| Infertility evaluation in fertile women: a model for assessing the efficacy of infertility testing | 31.7 | 0 | 2 |
| A prospective randomized crossover comparison of zygote intrafallopian transfer and in vitro fertilization-embryo transfer in unexplained infertility | 31.7 | 0 | 2 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 31.7 | 0 | 2 |
| Luteinizing hormone (LH) surge in patients using buserelin spray during ovarian stimulation for assisted reproduction | 31.7 | 0 | 2 |
| Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic | 31.7 | 0 | 2 |
| Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment | 31.7 | 0 | 2 |
| A comparison of early gestational age markers in viable twin pregnancies resulting from in vitro fertilization-embryo transfer versus spontaneous conception with ovarian stimulation | 31.7 | 0 | 2 |
| A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid | 31.7 | 0 | 2 |
| Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation | 31.7 | 0 | 2 |
| The influence of infertility treatment and assisted reproduction techniques on multiple pregnancy rates | 31.7 | 0 | 2 |
| Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| Embryo transfer: a critical step in assisted reproduction | 31.7 | 0 | 2 |
| A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation | 31.7 | 0 | 2 |
| Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer | 31.7 | 0 | 2 |
| Transfer of early-cleaved embryos increases implantation rate in patients undergoing ovarian stimulation and ICSI-embryo transfer | 31.7 | 0 | 2 |
| The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments | 31.7 | 0 | 2 |
| Infertility treatment and informed consent: current practices of reproductive endocrinologists | 31.7 | 0 | 2 |
| Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcome | 31.7 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction | 31.7 | 0 | 2 |
| Follitropin-alfa for ovarian stimulation during assisted reproduction treatment: a national collaborative study | 31.7 | 0 | 2 |
| Effectiveness and treatment for unexplained infertility | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 31.7 | 0 | 2 |
| [Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome] | 31.7 | 0 | 2 |
| Cervical dilatation with hygroscopic rods prior to ovarian stimulation facilitates embryo transfer | 31.7 | 0 | 2 |
| Elective single embryo transfer in assisted reproduction | 31.7 | 0 | 2 |
| Health of children born after the infertility treatment with Assisted Reproduction Technology | 31.7 | 0 | 2 |
| Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction | 31.7 | 0 | 2 |
| Blastocyst production and transfer in clinical assisted reproduction | 31.7 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction | 31.7 | 0 | 2 |
| Embryo splitting for infertility treatment | 31.7 | 0 | 2 |
| Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples | 31.7 | 0 | 2 |
| Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916) | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 31.7 | 0 | 2 |
| Elective single embryo transfer versus double embryo transfer in assisted reproduction | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results | 31.7 | 0 | 2 |
| Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: a committee opinion | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Results after assisted reproduction at a public fertility clinic | 31.7 | 0 | 2 |
| Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial | 31.7 | 0 | 2 |
| Strategies for hormonal ovarian stimulation in IVF, based on materials of the centre for assisted reproduction "varna" | 31.7 | 0 | 2 |
| Effect of different embryo transfer strategies on the outcome of assisted reproduction | 31.7 | 0 | 2 |
| Re: "Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births" | 31.7 | 0 | 2 |
| Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction | 31.7 | 0 | 2 |
| AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan | 31.7 | 0 | 2 |
| Re: Semen Analysis in Adolescent Cancer Patients prior to Bone Marrow Transplantation: When is it Too Late for Fertility Preservation? | 31.7 | 0 | 2 |
| Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH | 31.7 | 0 | 2 |
| Nurses as a support to improve the quality of life during assisted reproduction | 31.7 | 0 | 2 |
| Re: Fruit and Vegetable Intake and Their Pesticide Residues in Relation to Semen Quality among Men from a Fertility Clinic | 31.7 | 0 | 2 |
| Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques | 31.7 | 0 | 2 |
| Re: Semen Analysis in Adolescent Cancer Patients Prior to Bone Marrow Transplantation: When is it Too Late for Fertility Preservation? | 31.7 | 0 | 2 |
| Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers | 31.7 | 0 | 2 |
| Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal | 31.7 | 0 | 2 |
| Is gonadotropin ovarian stimulation for unexplained infertility any longer warranted? | 31.7 | 0 | 2 |
| Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility | 31.7 | 0 | 2 |
| Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline | 31.7 | 0 | 2 |
| Endometriosis does not affect live birth rates of patients submitted to assisted reproduction techniques: analysis of the Latin American Network Registry database from 1995 to 2011 | 31.7 | 0 | 2 |
| ASRM standard embryo transfer protocol template: a committee opinion | 31.7 | 0 | 2 |
| Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes | 31.7 | 0 | 2 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 31.7 | 0 | 2 |
| Timing of frozen-thawed embryo transfer after controlled ovarian stimulation in a non-elective freeze-all policy | 31.7 | 0 | 2 |
| Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization | 31.7 | 0 | 2 |
| Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols | 31.7 | 0 | 2 |
| Evidence-based treatments for couples with unexplained infertility: a guideline | 31.7 | 0 | 2 |
| Predictors of twin pregnancy after ovarian stimulation and intrauterine insemination in women with unexplained infertility | 31.7 | 0 | 2 |
| Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study | 31.7 | 0 | 2 |
| Single and double embryo transfer provide similar live birth rates in frozen cycles | 31.7 | 0 | 2 |
| Validation of a smartphone-based, computer-assisted sperm analysis system compared with laboratory-based manual microscopic semen analysis and computer-assisted semen analysis | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Ovarian stimulation for fertility preservation in women diagnosed with cancer | 31.7 | 0 | 2 |
| The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis | 31.7 | 0 | 2 |
| Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles | 31.7 | 0 | 2 |
| Patient-centered care: factors associated with reporting a positive experience at United States fertility clinics | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 31.7 | 0 | 2 |
| Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates | 31.7 | 0 | 2 |
| Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer | 31.7 | 0 | 2 |
| Prospective randomized trial comparing efficacy of letrozole step-up protocol with letrozole plus gonadotropins for controlled ovarian stimulation and intrauterine insemination in patients with unexplained infertility | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients | 31.7 | 0 | 2 |
| Oocyte exposure to supraphysiological estradiol during ovarian stimulation increased the risk of adverse perinatal outcomes after frozen-thawed embryo transfer: a retrospective cohort study | 31.7 | 0 | 2 |
| Effect of embryo transfer difficulty on live birth rates studied in vitrified-warmed euploid blastocyst transfers | 31.7 | 0 | 2 |
| Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response | 31.7 | 0 | 2 |
| Live birth rates and perinatal outcomes when all embryos are frozen compared with conventional fresh and frozen embryo transfer: a cohort study of 337,148 in vitro fertilisation cycles | 31.7 | 0 | 2 |
| Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial | 31.7 | 0 | 2 |
| Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial | 31.7 | 0 | 2 |
| Vaginal cuff dehiscence following controlled ovarian stimulation recognized during egg retrieval | 31.7 | 0 | 2 |
| Defining thresholds for abnormal premature progesterone levels during ovarian stimulation for assisted reproduction technologies | 31.7 | 0 | 2 |
| Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| [Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department] | 31.7 | 0 | 2 |
| Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study | 31.7 | 0 | 2 |
| Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population | 31.7 | 0 | 2 |
| Risk factors for inadequate response to ovarian stimulation in assisted reproduction cycles: systematic review | 31.7 | 0 | 2 |
| Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population | 31.7 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 31.7 | 0 | 2 |
| EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists | 31.7 | 0 | 2 |
| Measuring serum estradiol and progesterone one day prior to frozen embryo transfer improves live birth rates | 31.7 | 0 | 2 |
| Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility | 31.7 | 0 | 2 |
| [Cumulative live birth rates after frozen embryo transfer and fresh embryo transfer with oocyte numbers more than 15] | 31.7 | 0 | 2 |
| Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Could fertility clinics offer a sizable improvement of live birth rates by maturing post-GVBD oocytes in vitro? | 31.7 | 0 | 2 |
| Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation | 31.7 | 0 | 2 |
| Analysis of embryo quality with luteal phase ovarian stimulation after failed in vitro fertilization-embryo transfer with long or ultra-long protocol | 31.7 | 0 | 2 |
| Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility | 31.7 | 0 | 2 |
| Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle | 31.7 | 0 | 2 |
| Live Birth Rates in Poor Responders' Group after Previous Treatment with Autologous Platelet-Rich Plasma and Low Dose Ovarian Stimulation Compared with Poor Responders Used Only Low Dose Ovarian Stimulation Before in Vitro Fertilization | 31.7 | 0 | 2 |
| Ovarian stimulation for fertility preservation or family building in a cohort of transgender men | 31.7 | 0 | 2 |
| The Impact of Traditional Medicine-Based Lifestyle and Diet on Infertility Treatment in Women Undergoing Assisted Reproduction: A Randomized Controlled Trial | 31.7 | 0 | 2 |
| Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: a pilot study | 31.7 | 0 | 2 |
| Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act | 31.7 | 0 | 2 |
| Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment | 31.7 | 0 | 2 |
| Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population | 31.7 | 0 | 2 |
| Cumulative Live Birth Rates According to Maternal Body Mass Index After First Ovarian Stimulation for in vitro Fertilization: A Single Center Analysis of 14,782 Patients | 31.7 | 0 | 2 |
| Endometrial volume measured on the day of embryo transfer is not associated with live birth rates in IVF: a prospective study and review of the literature | 31.7 | 0 | 2 |
| No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies | 31.7 | 0 | 2 |
| [Elective single embryo transfer in assisted reproduction] | 31.7 | 0 | 2 |
| When is the optimal timing of frozen embryo transfer after controlled ovarian stimulation? | 31.7 | 0 | 2 |
| Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial | 31.7 | 0 | 2 |
| Changes in the levels of selected metabolites in the culture medium as a possible tool for the embryo selection in assisted reproduction | 31.7 | 0 | 2 |
| Value of sperm acrosin activity detection in selecting the method of assisted reproduction for patients with unexplained infertility | 31.7 | 0 | 2 |
| Effect of triple line vs isoechogenic endometrial texture on pregnancy outcome following embryo transfer according to use of controlled ovarian stimulation (COH) or estrogen/progesterone replacement | 31.7 | 0 | 2 |
| Low progesterone levels on the day before natural cycle frozen embryo transfer are negatively associated with live birth rates | 31.7 | 0 | 2 |
| Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study | 31.7 | 0 | 2 |
| How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Importance of early and precise ascertainment of mosaic Turner syndrome for fertility preservation and assisted reproduction counseling | 31.7 | 0 | 2 |
| Anti-Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4 | 31.7 | 0 | 2 |
| Customized Frozen Embryo Transfer after Identification of the Receptivity Window with a Transcriptomic Approach Improves the Implantation and Live Birth Rates in Patients with Repeated Implantation Failure | 31.7 | 0 | 2 |
| Use of a male antioxidant nutraceutical is associated with superior live birth rates during IVF treatment | 31.7 | 0 | 2 |
| Reduced live birth rates in frozen versus fresh single cleavage stage embryo transfer cycles: A cross -sectional study | 31.7 | 0 | 2 |
| IVM Survey Among Reproductive Medicine Specialists | 31.7 | 0 | 2 |
| Effect of uterine dimensions on live birth rates after single embryo transfer in infertile women | 31.7 | 0 | 2 |
| Corrigendum to ``Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial" [Reproductive BioMedicine Online, Volume 38, Issue 3, March 2019, Pages 387-396] | 31.7 | 0 | 2 |
| Ng Soon Chye | 31.7 | 0 | 2 |
| Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study | 31.7 | 0 | 2 |
| Further evidence that a supraphysiologic estradiol level during ovarian stimulation affects birthweight: findings of fresh and frozen embryo transfer with comparable estradiol levels on human chorionic gonadotropin trigger | 31.7 | 0 | 2 |
| Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction | 31.7 | 0 | 2 |
| Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day | 31.7 | 0 | 2 |
| Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis | 31.7 | 0 | 2 |
| Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible | 31.7 | 0 | 2 |
| Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment? | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| Access to infertility evaluation and treatment in two public fertility clinics and the reasons for withholding it: a prospective survey cohort study of healthcare professionals | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review | 31.7 | 0 | 2 |
| Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment | 31.7 | 0 | 2 |
| A Federated Blockchain Approach for Fertility Preservation and Assisted Reproduction in Smart Cities | 31.7 | 0 | 2 |
| Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger? | 31.7 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| Efficacy and Safety of Fertility Treatments and Fertility Preservation | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| Your Fertility Journey | 31.7 | 0 | 2 |
| P–087 Paternal age clinical effect on cumulative live birth rates (CLBR) per inseminated oocyte, embryo transfer and embryo transferred in autologous IVF-ICSI cycles of infertile males | 31.7 | 0 | 2 |
| P–090 Cumulative live birth rates (CLBR) per embryo transfer, embryo transferred and inseminated oocyte are not affected by paternal age in infertile male donor egg cycles | 31.7 | 0 | 2 |
| Pregnancy Rate (PR) With In-Vitro Fertilization (IVF) When the Egg Retrieval (ER) and the Embryo Transfer (ET) are Done by the Same Physician or by Different Physicians | 31.7 | 0 | 2 |
| Is Tubal Embryo Transfer (TET/ZIFT) of any Value? Meta-Analysis and Comparison with SART Data 1991–1996 | 31.7 | 0 | 2 |
| Endometriosis does not impact live birth rates in frozen embryo transfer (FET) of euploid blastocysts | 31.7 | 0 | 2 |
| Does PGT with fresh embryo transfer affect perinatal outcomes?: An analysis of the 2014 and 2015 SART data | 31.7 | 0 | 2 |
| Optimizing utilization of emotional support during infertility treatment | 31.7 | 0 | 2 |
| Towards personalised reproductive medicine: screening for genetic variants and its influence in controlled ovarian stimulation | 31.7 | 0 | 2 |
| Gonadotropin-specific follicular steroidogenesis in ovarian stimulation: evidence from the menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial | 31.7 | 0 | 2 |
| Time lapse selected elective single embryo transfer in hyaluronon enriched transfer medium in pcos improves live birth rates compared to use of conventional embryo transfer media. a possible alternative to freeze-all cycles in PCOS | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation | 31.7 | 0 | 2 |
| Risk of ectopic pregnancy after different ovarian stimulation protocols in fresh single embryo transfer: analysis of 71,831 cycles from the Japanese ART registry | 31.7 | 0 | 2 |
| Does Acupuncture Have Any Benefit in the IVF Treatment of Couples with Unexplained Infertility; A Prospective Randomized Controlled Trial | 31.7 | 0 | 2 |
| Selective Discontinuation of Luteal Phase Support in Assisted Reproduction Cycles Using a Gonadotropin-Releasing Hormone Agonist and Human Menopausal Gonadotropins for Ovarian Stimulation | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| What are the benefits and harms of intrauterine administration of human chorionic gonadotropin (hCG) around the time of embryo transfer for subfertile women undergoing assisted reproduction? | 31.7 | 0 | 2 |
| Recombinant FSH dosing during controlled ovarian stimulation in IVF treatment | 31.7 | 0 | 2 |
| Impact of the Duration of Controlled Ovarian Stimulation on Assisted Reproduction Cycle Outcomes | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| What Medically Assisted Reproduction Should Be Offered in Unexplained Infertility? | 31.7 | 0 | 2 |
| Singletons birthweight after frozen-thawed embryo transfer is increased after endometrial preparation with artificial cycle compared to mild gonadotropin ovarian stimulation | 31.7 | 0 | 2 |
| Ovarian stimulation is a safe and effective fertility preservation (FP) option in the adolescent population | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states | 31.7 | 0 | 2 |
| Random start versus conventional start controlled ovarian stimulation in women with cancer: comparing oocyte yield among fertility preservation cycles | 31.7 | 0 | 2 |
| Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment | 31.7 | 0 | 2 |
| Patient-centered care: factors associated with reporting a positive experience at U.S. fertility clinics | 31.7 | 0 | 2 |
| impact of breast cancer prognostic factors on the response to controlled ovarian stimulation patients undergoing fertility preservation | 31.7 | 0 | 2 |
| In freeze all embryos (FAE) cycles due to endometrial fluid (EF), live birth rates in subsequent frozen embryo transfer (FET) are comparable to those of controls, despite high rates of EF recurrence and cycle cancellation | 31.7 | 0 | 2 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 31.7 | 0 | 2 |
| Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction | 31.7 | 0 | 2 |
| Q137191222 | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| Journal of Contemporary History | 21.4 | 1 | 0 |
| National Center for Biotechnology Information | 21.4 | 1 | 0 |
| arXiv | 21.4 | 1 | 0 |
| March of Dimes Prize in Developmental Biology | 21.4 | 1 | 0 |
| Q180686 | 21.4 | 1 | 0 |
| Oregon Health and Science University | 21.4 | 1 | 0 |
| Journal of Egyptian Archaeology | 21.4 | 1 | 0 |
| eMedicine | 21.4 | 1 | 0 |
| Clinical Breast Cancer | 21.4 | 1 | 0 |
| Clinical Genitourinary Cancer | 21.4 | 1 | 0 |
| Clinical Colorectal Cancer | 21.4 | 1 | 0 |
| Clinical Lung Cancer | 21.4 | 1 | 0 |
| Francis Collins | 21.4 | 1 | 0 |
| American Congress of Obstetricians and Gynecologists | 21.4 | 1 | 0 |
| HomoloGene | 21.4 | 1 | 0 |
| United States Centers for Disease Control and Prevention | 21.4 | 1 | 0 |
| Cystic Fibrosis Foundation | 21.4 | 1 | 0 |
| Johns Hopkins School of Medicine | 21.4 | 1 | 0 |
| Blood | 21.4 | 1 | 0 |
| GenBank | 21.4 | 1 | 0 |
| Journal of Virology | 21.4 | 1 | 0 |
| Pennsylvania Hospital | 21.4 | 1 | 0 |
| Entrez | 21.4 | 1 | 0 |
| Johns Hopkins Hospital | 21.4 | 1 | 0 |
| Journal of Histochemistry and Cytochemistry | 21.4 | 1 | 0 |
| Journal of Marketing | 21.4 | 1 | 0 |
| Journal of Marketing Research | 21.4 | 1 | 0 |
| polymyalgia rheumatica | 21.4 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 21.4 | 1 | 0 |
| Journal of Peace Research | 21.4 | 1 | 0 |
| Journal of Cardiovascular Pharmacology and Therapeutics | 21.4 | 1 | 0 |
| Journal of the American Society of Echocardiography | 21.4 | 1 | 0 |
| Seminars in Cancer Biology | 21.4 | 1 | 0 |
| Cancer Treatment Reviews | 21.4 | 1 | 0 |
| Nanoscale Research Letters | 21.4 | 1 | 0 |
| Lou Ruvo Center for Brain Health | 21.4 | 1 | 0 |
| eLife | 21.4 | 1 | 0 |
| PeerJ | 21.4 | 1 | 0 |
| Biophysical Journal | 21.4 | 1 | 0 |
| Journal of Molecular and Cellular Cardiology | 21.4 | 1 | 0 |
| Journal of Cardiac Failure | 21.4 | 1 | 0 |
| Current Problems in Cardiology | 21.4 | 1 | 0 |
| Royal College of Obstetricians and Gynaecologists | 21.4 | 1 | 0 |
| Journal of Cardiovascular Magnetic Resonance | 21.4 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 21.4 | 1 | 0 |
| American Heart Journal | 21.4 | 1 | 0 |
| European Journal of Surgical Oncology | 21.4 | 1 | 0 |
| Cancer Biology and Therapy | 21.4 | 1 | 0 |
| Planned Parenthood | 21.4 | 1 | 0 |
| Cancer Imaging | 21.4 | 1 | 0 |
| Cardiology clinics | 21.4 | 1 | 0 |
| International Journal of Distributed Sensor Networks | 21.4 | 1 | 0 |
| Astrobiology | 21.4 | 1 | 0 |
| Pediatric Allergy, Immunology, and Pulmonology | 21.4 | 1 | 0 |
| Bioscience Reports | 21.4 | 1 | 0 |
| Environment and Planning | 21.4 | 1 | 0 |
| ACS Chemical Neuroscience | 21.4 | 1 | 0 |
| Acta Histochemica et Cytochemica | 21.4 | 1 | 0 |
| American Journal of Medicine | 21.4 | 1 | 0 |
| Analytical Chemistry Insights | 21.4 | 1 | 0 |
| Aging | 21.4 | 1 | 0 |
| Quarterly Journal of Experimental Psychology | 21.4 | 1 | 0 |
| Brigham and Women's Hospital | 21.4 | 1 | 0 |
| GeneReviews | 21.4 | 1 | 0 |
| Biomicrofluidics | 21.4 | 1 | 0 |
| Journal for the History of Astronomy | 21.4 | 1 | 0 |
| Journal of Experimental Medicine | 21.4 | 1 | 0 |
| Lipid Insights | 21.4 | 1 | 0 |
| Molecular and Cellular Biology | 21.4 | 1 | 0 |
| National Center for Health Statistics | 21.4 | 1 | 0 |
| WebMD | 21.4 | 1 | 0 |
| World Affairs | 21.4 | 1 | 0 |
| Eugene Koonin | 21.4 | 1 | 0 |
| Theology Today | 21.4 | 1 | 0 |
| Cell Calcium | 21.4 | 1 | 0 |
| Otolaryngologic Clinics of North America | 21.4 | 1 | 0 |
| AAOHN Journal | 21.4 | 1 | 0 |
| AIDS Research and Human Retroviruses | 21.4 | 1 | 0 |
| Acupuncture in Medicine | 21.4 | 1 | 0 |
| Advisory Committee on Immunization Practices | 21.4 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 21.4 | 1 | 0 |
| Alternative Law Journal | 21.4 | 1 | 0 |
| American Family Physician | 21.4 | 1 | 0 |
| American Journal of Alzheimer's Disease & Other Dementias | 21.4 | 1 | 0 |
| The American Journal of Emergency Medicine | 21.4 | 1 | 0 |
| American Journal of Evaluation | 21.4 | 1 | 0 |
| American Journal of Kidney Diseases | 21.4 | 1 | 0 |
| American Journal of Lifestyle Medicine | 21.4 | 1 | 0 |
| American Journal of Obstetrics and Gynecology | 21.4 | 1 | 0 |
| Annals of Family Medicine | 21.4 | 1 | 0 |
| Annals of Pharmacotherapy | 21.4 | 1 | 0 |
| Anne Schuchat | 21.4 | 1 | 0 |
| Antioxidants & Redox Signaling | 21.4 | 1 | 0 |
| Antiviral Therapy | 21.4 | 1 | 0 |
| Armed Forces & Society | 21.4 | 1 | 0 |
| Asia-Pacific Journal of Public Health | 21.4 | 1 | 0 |
| BabyCenter | 21.4 | 1 | 0 |
| Best Practice & Research: Clinical Rheumatology | 21.4 | 1 | 0 |
| Bioinformatics and Biology Insights | 21.4 | 1 | 0 |
| Biomarker Insights | 21.4 | 1 | 0 |
| California Management Review | 21.4 | 1 | 0 |
| Canadian Journal of Gastroenterology & Hepatology | 21.4 | 1 | 0 |
| Canadian Respiratory Journal | 21.4 | 1 | 0 |
| Cancer Informatics | 21.4 | 1 | 0 |
| Cerebral Cortex | 21.4 | 1 | 0 |
| City and Community | 21.4 | 1 | 0 |
| Clin-Alert | 21.4 | 1 | 0 |
| Clinical Gastroenterology and Hepatology | 21.4 | 1 | 0 |
| Clinical Lymphoma, Myeloma & Leukemia | 21.4 | 1 | 0 |
| Clinical Medicine Insights: Oncology | 21.4 | 1 | 0 |
| Clinical Ovarian Cancer & Other Gynecologic Malignancies | 21.4 | 1 | 0 |
| Clinical and Applied Thrombosis-Hemostasis | 21.4 | 1 | 0 |
| Clothing & Textiles Research Journal | 21.4 | 1 | 0 |
| Cn3D | 21.4 | 1 | 0 |
| Communication Research | 21.4 | 1 | 0 |
| Community College Review | 21.4 | 1 | 0 |
| Conceive | 21.4 | 1 | 0 |
| Concurrent Engineering | 21.4 | 1 | 0 |
| Conflict Management and Peace Science | 21.4 | 1 | 0 |
| Consensus CDS Project | 21.4 | 1 | 0 |
| Conserved Domain Database | 21.4 | 1 | 0 |
| Contemporary Sociology | 21.4 | 1 | 0 |
| Convergence | 21.4 | 1 | 0 |
| Cornell Hospitality Quarterly | 21.4 | 1 | 0 |
| Council on Foundations | 21.4 | 1 | 0 |
| Critical Social Policy | 21.4 | 1 | 0 |
| Cultural Sociology | 21.4 | 1 | 0 |
| CytoJournal | 21.4 | 1 | 0 |
| DNA and Cell Biology | 21.4 | 1 | 0 |
| Emerging Infectious Diseases | 21.4 | 1 | 0 |
| Dementia | 21.4 | 1 | 0 |
| Diabetes Care | 21.4 | 1 | 0 |
| Educational Evaluation & Policy Analysis | 21.4 | 1 | 0 |
| Educational Researcher | 21.4 | 1 | 0 |
| Election Law Journal | 21.4 | 1 | 0 |
| Emory Healthcare | 21.4 | 1 | 0 |
| Emory University Hospital | 21.4 | 1 | 0 |
| Emory University Hospital Midtown | 21.4 | 1 | 0 |
| Entrepreneurship Theory and Practice | 21.4 | 1 | 0 |
| Epi Map | 21.4 | 1 | 0 |
| Epidemic Intelligence Service | 21.4 | 1 | 0 |
| Ethnography | 21.4 | 1 | 0 |
| Eukaryotic Cell | 21.4 | 1 | 0 |
| European Journal of Medical Research | 21.4 | 1 | 0 |
| European Journal of Personality | 21.4 | 1 | 0 |
| European Psychiatry | 21.4 | 1 | 0 |
| European Union Politics | 21.4 | 1 | 0 |
| Evidence-based Complementary and Alternative Medicine | 21.4 | 1 | 0 |
| Evolutionary Bioinformatics | 21.4 | 1 | 0 |
| Feminist Criminology | 21.4 | 1 | 0 |
| Fire Fighter Fatality Investigation and Prevention Program | 21.4 | 1 | 0 |
| Foot and Ankle Specialist | 21.4 | 1 | 0 |
| Games and Culture | 21.4 | 1 | 0 |
| General Music Today | 21.4 | 1 | 0 |
| Genetic codes | 21.4 | 1 | 0 |
| Gifted Child Quarterly | 21.4 | 1 | 0 |
| Global Health Action | 21.4 | 1 | 0 |
| Health Hazard Evaluation | 21.4 | 1 | 0 |
| Hospital of the University of Pennsylvania | 21.4 | 1 | 0 |
| Howard County General Hospital | 21.4 | 1 | 0 |
| IBIS | 21.4 | 1 | 0 |
| ICAN: Infant, Child, & Adolescent Nutrition | 21.4 | 1 | 0 |
| IFLA Journal | 21.4 | 1 | 0 |
| Indian Journal of Nephrology | 21.4 | 1 | 0 |
| Information Development | 21.4 | 1 | 0 |
| International Communication Gazette | 21.4 | 1 | 0 |
| International Journal of Clinical and Experimental Medicine | 21.4 | 1 | 0 |
| International Journal of Clinical and Experimental Pathology | 21.4 | 1 | 0 |
| International Journal of Damage Mechanics | 21.4 | 1 | 0 |
| International Journal of Offender Therapy and Comparative Criminology | 21.4 | 1 | 0 |
| International Journal of Surgery | 21.4 | 1 | 0 |
| International Regional Science Review | 21.4 | 1 | 0 |
| Intervention in School and Clinic | 21.4 | 1 | 0 |
| Jeff Stein | 21.4 | 1 | 0 |
| Journal of Accounting, Auditing & Finance | 21.4 | 1 | 0 |
| Journal of Adolescent Research | 21.4 | 1 | 0 |
| Journal of Aging and Health | 21.4 | 1 | 0 |
| Journal of Alternative and Complementary Medicine | 21.4 | 1 | 0 |
| Journal of Applied Gerontology | 21.4 | 1 | 0 |
| Journal of Applied Social Science | 21.4 | 1 | 0 |
| Journal of Asian and African Studies | 21.4 | 1 | 0 |
| Journal of Bioactive and Compatible Polymers | 21.4 | 1 | 0 |
| Journal of Bone and Joint Surgery | 21.4 | 1 | 0 |
| Journal of Business Communication | 21.4 | 1 | 0 |
| Journal of Career Development | 21.4 | 1 | 0 |
| Journal of Cases in Educational Leadership | 21.4 | 1 | 0 |
| Journal of Computational Biology | 21.4 | 1 | 0 |
| Journal of Conflict Resolution | 21.4 | 1 | 0 |
| Journal of Cutaneous and Aesthetic Surgery | 21.4 | 1 | 0 |
| Journal of Disability Policy Studies | 21.4 | 1 | 0 |
| Journal of Educational and Behavioral Statistics | 21.4 | 1 | 0 |
| Journal of Empirical Research on Human Research Ethics | 21.4 | 1 | 0 |
| Journal of Evidence-Based Complementary & Alternative Medicine | 21.4 | 1 | 0 |
| Journal of Hospitality & Tourism Research | 21.4 | 1 | 0 |
| Journal of Industrial Textiles | 21.4 | 1 | 0 |
| Journal of Intensive Care Medicine | 21.4 | 1 | 0 |
| Journal of Laboratory Automation | 21.4 | 1 | 0 |
| Journal of Language and Social Psychology | 21.4 | 1 | 0 |
| Journal of Medical Ethics | 21.4 | 1 | 0 |
| Journal of Mixed Methods Research | 21.4 | 1 | 0 |
| Journal of Music Teacher Education | 21.4 | 1 | 0 |
| Journal of Palliative Medicine | 21.4 | 1 | 0 |
| Journal of Parenteral and Enteral Nutrition | 21.4 | 1 | 0 |
| Journal of Plastic Film and Sheeting | 21.4 | 1 | 0 |
| Journal of Psychology & Theology | 21.4 | 1 | 0 |
| Journal of Reinforced Plastics and Composites | 21.4 | 1 | 0 |
| Journal of Renal Nutrition | 21.4 | 1 | 0 |
| Journal of Sport & Social Issues | 21.4 | 1 | 0 |
| Journal of Studies in International Education | 21.4 | 1 | 0 |
| Journal of Teacher Education | 21.4 | 1 | 0 |
| Journal of Thermoplastic Composite Materials | 21.4 | 1 | 0 |
| Journal of Transcultural Nursing | 21.4 | 1 | 0 |
| Journal of the American Academy of Child and Adolescent Psychiatry | 21.4 | 1 | 0 |
| Journal of the American Medical Directors Association | 21.4 | 1 | 0 |
| Journal of the American Psychoanalytic Association | 21.4 | 1 | 0 |
| Journal of the Experimental Analysis of Behavior | 21.4 | 1 | 0 |
| Journal of the International AIDS Society | 21.4 | 1 | 0 |
| Journal of the Renin-Angiotensin-Aldosterone System | 21.4 | 1 | 0 |
| Journalism & Mass Communication Quarterly | 21.4 | 1 | 0 |
| Language Testing | 21.4 | 1 | 0 |
| Mayo Clinic Proceedings | 21.4 | 1 | 0 |
| The Linacre Quarterly | 21.4 | 1 | 0 |
| Lupus | 21.4 | 1 | 0 |
| Systems Biology in Reproductive Medicine | 20.0 | 0 | 1 |
| Robert Edwards | 20.0 | 0 | 1 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| reproductive medicine | 20.0 | 0 | 1 |
| Unexplained infertility | 20.0 | 0 | 1 |
| azoospermia | 20.0 | 0 | 1 |
| doctor–patient relationship | 20.0 | 0 | 1 |
| egg donation | 20.0 | 0 | 1 |
| semen analysis | 20.0 | 0 | 1 |
| Creighton Model FertilityCare System | 20.0 | 0 | 1 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| Volunteer Emotional Support Helplines | 20.0 | 0 | 1 |
| Volks | 20.0 | 0 | 1 |
| AirCraft Casualty Emotional Support Services | 20.0 | 0 | 1 |
| Bedside Manner | 20.0 | 0 | 1 |
| Bedside manner | 20.0 | 0 | 1 |
| Center for Reproductive Medicine | 20.0 | 0 | 1 |
| covert incest | 20.0 | 0 | 1 |
| emotional support animal | 20.0 | 0 | 1 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| fertility preservation | 20.0 | 0 | 1 |
| Fertility testing | 20.0 | 0 | 1 |
| fertility tourism | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |